#161 – AMA #23: All Things Nicotine: deep dive into its cognitive and physical benefits, risks, and mechanisms of action
“It’s so fascinating to me frankly that one molecule found in nature can be so potent. It’s hard to imagine you could engineer a drug to do this.” —Peter Attia
Does NMN improve metabolic health in humans?
Thoughts on the first efficacy trial recently published
#155 – Chris Sonnenday, M.D.: The history, challenges, and gift of organ transplantation
“Knowing that their loved one’s organs live on in another individual and saved their life is the only good thing about what was otherwise the worst day of their lives … I think it’s important for people to hear that it can be a transformative gift.” — Chris Sonnenday
Promise and challenges for psilocybin and MDMA use in treatment
What lies ahead before FDA approval
#150 – Senator Bill Frist, M.D.: A modern Renaissance man’s journey through science, politics, and business
“Public health has been the stepchild of health and welfare and healing. That is inverted now, and people appreciate it, but are we going to actually deliver on it? Not just next year, and not just put more funding in it, but really do it over a period of time?” —Bill Frist
#148 – Richard Miller, M.D., Ph.D.: The gold standard for testing longevity drugs: the Interventions Testing Program
“I don’t really care what causes aging. What I care about is: What is the process that can postpone all the different aspects of aging?” — Rich Miller
#132 – AMA #16: Exploring hot and cold therapy
“All of the work that went into this analysis earlier in the year, it really changed my tune. And I think I’m now at the point where I kind of want to have a sauna, frankly, in the tool kit for longevity.” — Peter Attia
#103 – Looking back on the first 99 episodes: Strong Convictions, Loosely Held
“I reserve metformin prescriptions for patients who obviously are in need of it from the standpoint of glucose and insulin regulation, but I don’t view it really as a pro longevity agent yet.” — Peter Attia
#83 – Bill Harris, Ph.D.: Omega-3 fatty acids
“I don’t think [omega-6] is the evil that people think it is. The problem is that we need to get more EPA and DHA in our diet, not necessarily get all hung up on omega-6.” — Bill Harris
#81 – Debra Kimless, M.D. & Steve Goldner, J.D.: Cannabis – the latest science on CBD & THC
“Cannabis is a gateway more towards health than to other drugs.” —Steve Goldner